Skip to content

    Sage is a seed to Series D stage investment firm. It has made 11 investments. Their most common stage is series-a (42% of deals). Average disclosed round size is $57.3M (across 11 rounds with reported amounts).

    Find people at Sage on Goldilocks AI

    Portfolio

    11

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    0

    Team

    SL

    Simon Longbottom

    Chief Growth Officer

    AH

    Aaron Harris

    Chief Technology Officer

    AC

    Amanda Cusdin

    Chief People Officer

    AS

    Anand Swaminathan

    Chief Strategy Officer

    DB

    Derk Bleeker

    Chief commercial officer

    JC

    Jacqui Cartin

    Chief Financial Officer

    KV

    Krish Vitaldevara

    Chief Product Officer

    SH

    Steve Hare

    Chief Executive Officer

    VB

    Vicki Bradin

    General Counsel and Company Secretary

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    12 investments
    CompanyRoundAmountDate
    Insilico Medicine logoInsilico MedicineSeries C$255MJun 2021
    和和誉生物Series D$123MJan 2021
    AAbbisko TherapeuticsSeries D$123MJan 2021
    Glanris logoGlanrisSeries A$2MJan 2021
    Liftoff logoLiftoffSeries A$5MFeb 2015
    AArbor Surgical TechnologiesSeries B$20MAug 2005
    PeerJ logoPeerJSeries A——
    AnHeart Therapeutics logoAnHeart TherapeuticsSeries B$61M—
    Datavations logoDatavationsSeed$4.2M—
    NLX logoNLXSeed$5M—
    Recuro Health logoRecuro HealthSeries A$15M—
    Datavations logoDatavationsSeries A$17M—

    Top Co-Investors

    Last updated: 7 October 2026